" class="no-js "lang="en-US"> Fundraising Archives - Page 10 of 41 - Medtech Alert
Tuesday, September 23, 2025

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

HighTide Therapeutics Raises $107 Million in Series Financing to Advance Innovative Pipeline and Business Collaborations

HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and […]

Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital

Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]

Actimed Therapeutics Closes Second Tranche of £10m Seed Financing

Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]

PVmed Raises US $14 Million Series A Funding

Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]

Anocca Secures €25 Million from the European Investment Bank to Support Development of T-cell Therapies for Cancer

Anocca, a fully integrated cell therapy biotechnology company, has announced that it has secured €25 […]

Biomica Raises $20 Million in a Funding Round to Advance its Pipeline of Microbiome-based Therapeutics

Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene, has […]

Drug Safety Prediction AI Startup Quris Earns Additional Seed Funding Led by SoftBank Vision Fund 2

Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, has announced it has secured […]

Trinity Capital Provides $25 Million Growth Capital To RxAnte

Trinity Capital, a leading provider of diversified financial solutions to growth-stage companies, has announced a […]

Gilgamesh Pharmaceuticals Raises $39 Million in Series B Funding to Advance Mental Health Treatments

Gilgamesh Pharmaceuticals, a biotechnology company developing a portfolio of rapid-acting and durable treatments for depression […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more